Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon
Background: The optimal therapeutic strategy for coronary intervention in edge in-stent restenosis (edge ISR) remains less well-defined. Aim: The aim of this study was to assess 12-month outcomes of re-stenting using drug-eluting stents (DESs) versus using drug-eluting balloon (DEB) for managing cor...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
| Series: | Journal of Indian College of Cardiology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/jicc.jicc_36_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background:
The optimal therapeutic strategy for coronary intervention in edge in-stent restenosis (edge ISR) remains less well-defined.
Aim:
The aim of this study was to assess 12-month outcomes of re-stenting using drug-eluting stents (DESs) versus using drug-eluting balloon (DEB) for managing coronary edge ISR.
Patients and Methods:
One hundred and four patients with edge ISR were randomly assigned to either DES or DEB. The primary endpoint was stent failure at 12-month follow-up.
Results:
Significantly lower target vessel revascularization among the DEB group compared to restenting group, (7.7% vs. 23.1%, P = 0.04). Likewise, target vessel-related myocardial infarction rate was significantly lower among the DEB group than restenting (5.7% vs. 23.1%, P = 0.04). On the other hand, there were no significant differences in the rates of deaths or restenosis between the two groups.
Conclusion:
The DEB is superior to the DES with better both safety and efficacy. |
|---|---|
| ISSN: | 1561-8811 2213-3615 |